Implanet S.A. (FRA:IM11)

Germany · Delayed Price · Currency is EUR

0.1652

-0.0118 (-6.67%)

At close: Jun 26, 2026

83.56% (1Y)

Market Cap	24.42M +97.4%
Revenue (ttm)	12.47M +32.6%
Net Income	-4.38M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	48,320
Open	0.1568
Previous Close	0.1770
Day's Range	0.1568 - 0.1674
52-Week Range	0.0784 - 0.4280
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 15, 2026

About Implanet

Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-Jazz Screw systems for posterior fixation. It also provides an ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. The co... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2006

Employees 46

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol IM11

Financial Performance

In 2025, Implanet's revenue was 12.47 million, an increase of 32.62% compared to the previous year's 9.41 million. Losses were -4.38 million, 0.37% more than in 2024.

Financial Statements